Contact
Please use this form to send email to PR contact of this press release:
Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme
TO:
Please use this form to send email to PR contact of this press release:
Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme
TO: